Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 560, Issue 1, 2004, Pages 79-89

  Wise, Sandra S ^a   Holmes, Amie L ^a   Ketterer, Michael E ^b   Hartsock, Wendy J ^b   Fomchenko, Elena ^c   Katsifis, Spiros ^c   Thompson, W Douglas ^a   Wise Sr , John Pierce ^a  

^a UNIVERSITY OF SOUTHERN MAINE   (United States)

^b NORTHERN ARIZONA UNIVERSITY   (United States)

^c UNIVERSITY OF BRIDGEPORT   (United States)

Author keywords

Chromium; Chromosomal aberrations; Clastogenicity; Cytotoxicity; Genotoxicity; Lead chromate; Lung cancer; Sodium chromate; WTHBF 6 cells

Indexed keywords

CHROMIC ACID; CHROMIUM; CLASTOGEN; GLUTAMIC ACID; LEAD; SODIUM CHROMATE;

ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG CARCINOGENESIS; METAPHASE; PRIORITY JOURNAL; SPECIES DIFFERENCE;

BRONCHI; CELL LINE; CHROMATES; CHROMIUM; HUMANS; LEAD; MUTAGENS;

EID: 4043084819     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.02.009     Document Type: Article

References (23)

1. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Chromium, Nickel and Welding, vol. 49, International Agency for Research on Cancer, Lyons, France, 1990.
2. Léonard A., Lauwerys R.R. Carcinogenicity and mutagenicity of chromium. Mutat. Res. 76:1980;227-239.
3. Levy L.S., Vanitt S. Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia. Carcinogenesis. 7:1986;831-835.
4. Patierno S.R., Banh D., Landolph J.R. Transformation of C3H/10T1/2 mouse embryo cells by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 47:1988;3815-3823.
5. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., Tsuchiya E. Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study. Br. J. Cancer. 70:1994;160-166.
6. Ishikawa Y., Nakagawa K., Satoh Y., Kitagawa T., Sugano H., Hirano T., Tsuchiya E. "Hot spots" of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res. 54:1994;2342-2346.
7. Xu J., Wise J.P., Patierno S.R. DNA damage induced by lead chromate in cultured mammalian cells. Mutat. Res. 280:1992;129-136.
8. Blankenship J.J., Carlisle D., Wise J.P. Sr., Orenstein J.M., Dye L.E., Patierno S.R. Induction of apoptotic cell death by particulate lead chromate: differential effects of Vitamins C and E on genotoxicity and survival. Toxicol. Appl. Pharm. 146:1997;270-280.
9. 4 in hamster and human cells. Mutat. Res. 278:1992;69-79.
10. Wise J.P., Orenstein J.M., Patierno S.R. Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake. Carcinogenesis. 14:1993;429-434.
11. Wise J.P. Sr., Stearns D.M., Wetterhahn K.E., Patierno S.R. Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis. Carcinogenesis. 15:1994;2249-2254.
12. Wise J.P. Sr., Wise S.S., Little J.E. The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells. Mutat. Res. 517:2002;221-229.
13. Wise S.S., Elmore L.W., Holt S.E., Little J.E., Bryant B.H. J.P. Wise Sr., Telomerase-mediated lifespan extension of human bronchial cells does not affect hexavalent chromium-induced cytotoxicity or genotoxicity. Mol. Cell. Biochem. 255:2004;103-111.
14. Singh J., Pritchard D.E., Carlisle D.L., Mclean J.A., Montaser A., Orenstein J.M., Patierno S.R. Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol. Appl. Pharm. 161:1999;240-248.
15. Elias Z., Poirot O., Baruthio F., Daniere M.C. Role of solubilized chromium in the induction of morphological transformation of Syrian hamster embryo (SHE) cells by particulate Cr(VI) compounds. Carcinogenesis. 12:1991;1811-1816.
16. National Occupational Exposure Survey, National Institute for Occupational Safety and Health, Cincinnati, OH, 1988.
17. Johnson B.L., DeRosa C.T. The toxicological hazard of superfund hazardous waste sites. Rev. Environ. Health. 12(4):1997;235-251.
18. Burke T., Fagliano J., Goldoft M., Hazen R.E., Inglewicz R., McKee T. Chromite ore processing residue in Hudson County, New Jersey. Environ. Health Perspect. 92:1991;131-137.
19. Smith C.J., Livingston S.D., Doolittle D.J. An international literature survey of IARC Group. I. Carcinogens reported in mainstream cigarette smoke. Food Chem. Toxicol. 35:1997;1107-1130.
20. Damage and Threats Caused by Hazardous Materials Sites, EPA/430-9-80/004, US Environmental Protection Agency, Washington DC, 1980.
21. Falerios M., Schild L., Sheehan P., Paustenbach D.J. Airborne concentrations of trivalent and hexavalent chromium from contaminated soils at unpaved and partially paved commercial/industrial sites. J. Air Waste Manage. Assoc. 42:1992;40-48.
22. Zelifoff J.T., Li J.H., Hartwig A., Wang X.W., Costa M., Rossman T.G. Genetic toxicology of lead compounds. Carcinogenesis. 9:1988;1727-1732.
23. 51Cr(VI) by human erythrocytes: evidence for a carrier-mediated transport mechanism Sci. Total Environ. 71:1988;561-566.